In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: CVS Health’s current price sits 6.5% below the high-confidence fair value of $94.93, indicating modest upside potential amid valuation method discrepancies. Financial health scores are weak, signaling operational and profitability challenges despite moderate growth expectations. Monte Carlo results show high volatility and significant downside risk (27.8%), reflecting uncertain future outcomes and investment risk.